β-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced Senescence in Prelymphomagenic Thymocytes In Vivo

REFERENCES

• Bartkova, J., N. Rezaei, M. Liontos, P. Karakaidos, D. Kletsas, N. Issaeva, L. V. Vassiliou, E. Kolettas, K. Niforou, V. C. Zoumpourlis, M. Takaoka, H. Nakagawa, F. Tort, K. Fugger, F. Johansson, M. Sehested, C. L. Andersen, L. Dyrskjot, T. Orntoft, J. Lukas, C. Kittas, T. Helleday, T. D. Halazonetis, J. Bartek, and V. G. Gorgoulis. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637.
   PubMed Web of Science ®Google Scholar
• Braig, M., S. Lee, C. Loddenkemper, C. Rudolph, A. H. Peters, B. Schlegelberger, H. Stein, B. Dorken, T. Jenuwein, and C. A. Schmitt. 2005. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436:660–665.
   PubMed Web of Science ®Google Scholar
• Campisi, J. 2001. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:S27–S31.
   PubMed Web of Science ®Google Scholar
• Chen, H. T., A. Bhandoola, M. J. Difilippantonio, J. Zhu, M. J. Brown, X. Tai, E. P. Rogakou, T. M. Brotz, W. M. Bonner, T. Ried, and A. Nussenzweig. 2000. Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science 290:1962–1965.
   PubMed Web of Science ®Google Scholar
• Chen, Z., L. C. Trotman, D. Shaffer, H. K. Lin, Z. A. Dotan, M. Niki, J. A. Koutcher, H. I. Scher, T. Ludwig, W. Gerald, C. Cordon-Cardo, and P. P. Pandolfi. 2005. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436:725–730.
   PubMed Web of Science ®Google Scholar
• Collado, M., J. Gil, A. Efeyan, C. Guerra, A. J. Schuhmacher, M. Barradas, A. Benguria, A. Zaballos, J. M. Flores, M. Barbacid, D. Beach, and M. Serrano. 2005. Tumour biology: senescence in premalignant tumours. Nature 436:642.
   PubMed Web of Science ®Google Scholar
• Damalas, A., S. Kahan, M. Shtutman, A. Ben-Ze'ev, and M. Oren. 2001. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 20:4912–4922.
   PubMedGoogle Scholar
• Difilippantonio, M. J., S. Petersen, H. T. Chen, R. Johnson, M. Jasin, R. Kanaar, T. Ried, and A. Nussenzweig. 2002. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196:469–480.
   PubMedGoogle Scholar
• Difilippantonio, M. J., J. Zhu, H. T. Chen, E. Meffre, M. C. Nussenzweig, E. E. Max, T. Ried, and A. Nussenzweig. 2000. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404:510–514.
   PubMed Web of Science ®Google Scholar
• Di Micco, R., M. Fumagalli, A. Cicalese, S. Piccinin, P. Gasparini, C. Luise, C. Schurra, M. Garre, P. G. Nuciforo, A. Bensimon, R. Maestro, P. G. Pelicci, and F. d'Adda di Fagagna. 2006. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444:638–642.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Dudley, E. C., H. T. Petrie, L. M. Shah, M. J. Owen, and A. C. Hayday. 1994. T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1:83–93.
   PubMed Web of Science ®Google Scholar
• Gat, U., R. DasGupta, L. Degenstein, and E. Fuchs. 1998. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95:605–614.
   PubMed Web of Science ®Google Scholar
• Godfrey, D. I., J. Kennedy, P. Mombaerts, S. Tonegawa, and A. Zlotnik. 1994. Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3−CD4−CD8− thymocyte differentiation. J. Immunol. 152:4783–4792.
   PubMed Web of Science ®Google Scholar
• Gounari, F., I. Aifantis, K. Khazaie, S. Hoeflinger, N. Harada, M. M. Taketo, and H. von Boehmer. 2001. Somatic activation of beta-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development. Nat. Immunol. 2:863–869.
   PubMedGoogle Scholar
• Gounari, F., R. Chang, J. Cowan, Z. Guo, M. Dose, E. Gounaris, and K. Khazaie. 2005. Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat. Immunol. 6:800–809.
   PubMedGoogle Scholar
• Grade, M., B. M. Ghadimi, S. Varma, R. Simon, D. Wangsa, L. Barenboim-Stapleton, T. Liersch, H. Becker, T. Ried, and M. J. Difilippantonio. 2006. Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. Cancer Res. 66:267–282.
   PubMedGoogle Scholar
• Gregorieff, A., and H. Clevers. 2005. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 19:877–890.
   PubMed Web of Science ®Google Scholar
• Guidos, C. J., C. J. Williams, I. Grandal, G. Knowles, M. T. Huang, and J. S. Danska. 1996. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10:2038–2054.
   PubMedGoogle Scholar
• Guo, Z., M. Dose, D. Kovalovsky, R. Chang, J. O'Neil, A. T. Look, H. von Boehmer, K. Khazaie, and F. Gounari. 2007. Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood 109:5463–5472.
   PubMedGoogle Scholar
• Haines, B. B., C. J. Ryu, S. Chang, A. Protopopov, A. Luch, Y. H. Kang, D. D. Draganov, M. F. Fragoso, S. G. Paik, H. J. Hong, R. A. DePinho, and J. Chen. 2006. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations. Cancer Cell 9:109–120.
   PubMedGoogle Scholar
• Haks, M. C., P. Krimpenfort, J. H. van den Brakel, and A. M. Kruisbeek. 1999. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 11:91–101.
   PubMedGoogle Scholar
• Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M. M. Taketo. 1999. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18:5931–5942.
   PubMed Web of Science ®Google Scholar
• Harris, S. L., and A. J. Levine. 2005. The p53 pathway: positive and negative feedback loops. Oncogene 24:2899–2908.
   PubMed Web of Science ®Google Scholar
• He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512.
   PubMed Web of Science ®Google Scholar
• Honeycutt, K. A., and D. R. Roop. 2004. c-Myc and epidermal stem cell fate determination. J. Dermatol. 31:368–375.
   PubMedGoogle Scholar
• Jiang, D., M. J. Lenardo, and J. C. Zuniga-Pflucker. 1996. p53 prevents maturation to the CD4+CD8+ stage of thymocyte differentiation in the absence of T cell receptor rearrangement. J. Exp. Med. 183:1923–1928.
   PubMedGoogle Scholar
• Kinzler, K. W., and B. Vogelstein. 1996. Lessons from hereditary colorectal cancer. Cell 87:159–170.
   PubMed Web of Science ®Google Scholar
• Kirstetter, P., K. Anderson, B. T. Porse, S. E. Jacobsen, and C. Nerlov. 2006. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat. Immunol. 7:1048–1056.
   PubMed Web of Science ®Google Scholar
• Lee, G. S., M. B. Neiditch, S. S. Salus, and D. B. Roth. 2004. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 117:171–184.
   PubMed Web of Science ®Google Scholar
• Li, G. C., H. Ouyang, X. Li, H. Nagasawa, J. B. Little, D. J. Chen, C. C. Ling, Z. Fuks, and C. Cordon-Cardo. 1998. Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol. Cell 2:1–8.
   PubMed Web of Science ®Google Scholar
• Liao, M. J., X. X. Zhang, R. Hill, J. Gao, M. B. Qumsiyeh, W. Nichols, and T. Van Dyke. 1998. No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol. Cell. Biol. 18:3495–3501.
   PubMedGoogle Scholar
• Liyanage, M., A. Coleman, S. du Manoir, T. Veldman, S. McCormack, R. B. Dickson, C. Barlow, A. Wynshaw-Boris, S. Janz, J. Wienberg, M. A. Ferguson-Smith, E. Schrock, and T. Ried. 1996. Multicolour spectral karyotyping of mouse chromosomes. Nat. Genet. 14:312–315.
   PubMed Web of Science ®Google Scholar
• Lo Celso, C., D. M. Prowse, and F. M. Watt. 2004. Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development 131:1787–1799.
   PubMed Web of Science ®Google Scholar
• Mallette, F. A., M. F. Gaumont-Leclerc, and G. Ferbeyre. 2007. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 21:43–48.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., I. Pérez De Castro, M. I. Hernández, M. Jiménez, T. Corral, and A. Pellicer. 2000. Cellular response to oncogenic Ras involves induction of the Cdk4 and Cdk6 inhibitor p15INK4b. Mol. Cell. Biol. 20:2915–2925.
   PubMedGoogle Scholar
• Michaelson, J. S., and P. Leder. 2001. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20:5093–5099.
   PubMed Web of Science ®Google Scholar
• Michaloglou, C., L. C. Vredeveld, M. S. Soengas, C. Denoyelle, T. Kuilman, C. M. van der Horst, D. M. Majoor, J. W. Shay, W. J. Mooi, and D. S. Peeper. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720–724.
   PubMed Web of Science ®Google Scholar
• Mulroy, T., J. A. McMahon, S. J. Burakoff, A. P. McMahon, and J. Sen. 2002. Wnt-1 and Wnt-4 regulate thymic cellularity. Eur. J. Immunol. 32:967–971.
   PubMed Web of Science ®Google Scholar
• Mulroy, T., Y. Xu, and J. M. Sen. 2003. Beta-catenin expression enhances generation of mature thymocytes. Int. Immunol. 15:1485–1494.
   PubMedGoogle Scholar
• Nacht, M., and T. Jacks. 1998. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Differ. 9:131–138.
   PubMedGoogle Scholar
• Okamura, R. M., M. Sigvardsson, J. Galceran, S. Verbeek, H. Clevers, and R. Grosschedl. 1998. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8:11–20.
   PubMed Web of Science ®Google Scholar
• Pinto, D., and H. Clevers. 2005. Wnt control of stem cells and differentiation in the intestinal epithelium. Exp. Cell Res. 306:357–363.
   PubMed Web of Science ®Google Scholar
• Polakis, P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837–1851.
   PubMed Web of Science ®Google Scholar
• Pongracz, J. E., S. M. Parnell, T. Jones, G. Anderson, and E. J. Jenkinson. 2006. Overexpression of ICAT highlights a role for catenin-mediated canonical Wnt signalling in early T cell development. Eur. J. Immunol. 36:2376–2383.
   PubMed Web of Science ®Google Scholar
• Reschly, E. J., C. Spaulding, T. Vilimas, W. V. Graham, R. L. Brumbaugh, I. Aifantis, W. S. Pear, and B. L. Kee. 2006. Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood 107:4115–4121.
   PubMed Web of Science ®Google Scholar
• Reya, T., A. W. Duncan, L. Ailles, J. Domen, D. C. Scherer, K. Willert, L. Hintz, R. Nusse, and I. L. Weissman. 2003. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409–414.
   PubMed Web of Science ®Google Scholar
• Ridgeway, A. G., J. McMenamin, and P. Leder. 2006. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells. Oncogene 25:3518–3527.
   PubMedGoogle Scholar
• Rogakou, E. P., C. Boon, C. Redon, and W. M. Bonner. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:905–916.
   PubMed Web of Science ®Google Scholar
• Rooney, S., F. W. Alt, J. Sekiguchi, and J. P. Manis. 2005. Artemis-independent functions of DNA-dependent protein kinase in Ig heavy chain class switch recombination and development. Proc. Natl. Acad. Sci. USA 102:2471–2475.
   PubMedGoogle Scholar
• Rooney, S., J. Sekiguchi, S. Whitlow, M. Eckersdorff, J. P. Manis, C. Lee, D. O. Ferguson, and F. W. Alt. 2004. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc. Natl. Acad. Sci. USA 101:2410–2415.
   PubMedGoogle Scholar
• Scheller, M., J. Huelsken, F. Rosenbauer, M. M. Taketo, W. Birchmeier, D. G. Tenen, and A. Leutz. 2006. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat. Immunol. 7:1037–1047.
   PubMed Web of Science ®Google Scholar
• Schilham, M. W., A. Wilson, P. Moerer, B. J. Benaissa-Trouw, A. Cumano, and H. C. Clevers. 1998. Critical involvement of Tcf-1 in expansion of thymocytes. J. Immunol. 161:3984–3991.
   PubMed Web of Science ®Google Scholar
• Serinsoz, E., M. Neusch, G. Busche, R. Wasielewski, H. Kreipe, and O. Bock. 2004. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia. Br. J. Haematol. 126:313–319.
   PubMed Web of Science ®Google Scholar
• Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602.
   PubMed Web of Science ®Google Scholar
• Sharpless, N. E., and R. A. DePinho. 2005. Cancer: crime and punishment. Nature 436:636–637.
   PubMed Web of Science ®Google Scholar
• Shelton, D. N., E. Chang, P. S. Whittier, D. Choi, and W. D. Funk. 1999. Microarray analysis of replicative senescence. Curr. Biol. 9:939–945.
   PubMed Web of Science ®Google Scholar
• Sicinska, E., I. Aifantis, L. Le Cam, W. Swat, C. Borowski, Q. Yu, A. A. Ferrando, S. D. Levin, Y. Geng, H. von Boehmer, and P. Sicinski. 2003. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4:451–461.
   PubMed Web of Science ®Google Scholar
• Staal, F. J., J. Meeldijk, P. Moerer, P. Jay, B. C. van de Weerdt, S. Vainio, G. P. Nolan, and H. Clevers. 2001. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Eur. J. Immunol. 31:285–293.
   PubMedGoogle Scholar
• Talora, C., S. Cialfi, C. Oliviero, R. Palermo, M. Pascucci, L. Frati, A. Vacca, A. Gulino, and I. Screpanti. 2006. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis. Blood 107:3313–3320.
   PubMedGoogle Scholar
• Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426.
   PubMed Web of Science ®Google Scholar
• van Meerwijk, J. P., H. Bluthmann, and M. Steinmetz. 1990. T-cell specific rearrangement of T-cell receptor beta transgenes in mice. EMBO J. 9:1057–1062.
   PubMedGoogle Scholar
• von Boehmer, H. 2005. Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate. Nat. Rev. Immunol. 5:571–577.
   PubMedGoogle Scholar
• Weerkamp, F., J. J. van Dongen, and F. J. Staal. 2006. Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia 20:1197–1205.
   PubMed Web of Science ®Google Scholar
• Xu, Y., D. Banerjee, J. Huelsken, W. Birchmeier, and J. M. Sen. 2003. Deletion of beta-catenin impairs T cell development. Nat. Immunol. 4:1177–1182.
   PubMedGoogle Scholar
• Xu, Y., and J. Sen. 2003. Beta-catenin expression in thymocytes accelerates thymic involution. Eur. J. Immunol. 33:12–18.
   PubMedGoogle Scholar
• Yu, Q., and J. M. Sen. 2007. Beta-catenin regulates positive selection of thymocytes but not lineage commitment. J. Immunol. 178:5028–5034.
   PubMedGoogle Scholar
• Zhu, C., K. D. Mills, D. O. Ferguson, C. Lee, J. Manis, J. Fleming, Y. Gao, C. C. Morton, and F. W. Alt. 2002. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109:811–821.
   PubMed Web of Science ®Google Scholar